Ken Griffin Renalytix PLC Put Options Transaction History

Citadel Advisors LLC

  • $559 Billion
  • Q4 2024

Put Options

5 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q3 2023

Nov 14, 2023
SELL
$1.51 - $4.01 $302 - $802
-200 Reduced 2.11%
9,300 $14,000
Q2 2023

Aug 14, 2023
SELL
$2.0 - $2.92 $400 - $584
-200 Reduced 2.06%
9,500 $27,000
Q1 2023

May 15, 2023
BUY
$1.93 - $3.72 $6,176 - $11,904
3,200 Added 49.23%
9,700 $23,000
Q4 2022

Feb 14, 2023
SELL
$1.06 - $2.21 $14,098 - $29,393
-13,300 Reduced 67.17%
6,500 $12,000
Q3 2022

Nov 14, 2022
BUY
$1.19 - $2.78 $9,758 - $22,796
8,200 Added 70.69%
19,800 $25,000

Others Institutions Holding RNLX

# of Institutions
4
Shares Held
421K
Call Options Held
0
Put Options Held
0
View Full List

About Renalytix plc

RNLX Quotes by TradingView
  • Ticker RNLX
  • Exchange OTC
  • Sector Healthcare
  • Industry Health Information Services
  • Shares Outstandng 37,445,900
  • Market Cap $5.62M
  • Description
  • Renalytix Plc develops artificial intelligence-enabled in vitro diagnostic solutions for kidney diseases. The company offers KidneyIntelX, a diagnostic platform that employs an artificial intelligence-enabled algorithm that combines various data inputs, including validated blood-based biomarkers, inherited genetics and personalized patient data ...
More about RNLX
Track Ken Griffin's Portfolio

Track Ken Griffin Portfolio

Follow Ken Griffin (Citadel Advisors LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email